Lu Liyan, Li Yuehua, Li Wenbin
Department of Radiology, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai, 200233, China.
Adv Ther. 2016 Jul;33(7):1158-68. doi: 10.1007/s12325-016-0352-3. Epub 2016 Jun 13.
Pilot studies have suggested potential clinical applications for intravoxel incoherent motion (IVIM) magnetic resonance imaging (MRI) in head and neck cancers. This study aimed to characterize metastatic lymph nodes using IVIM MRI, and to evaluate the role of IVIM MRI in the prediction of the early treatment response of lymph node metastasis from nasopharyngeal carcinoma (NPC).
A total of 122 patients with metastatic lymph nodes from NPC underwent two MRI examinations, pre-treatment and post-treatment (at 4 weeks and at ≥2 years from the end of chemoradiotherapy). Treatment response was assessed using the Response Evaluation Criteria in Solid Tumors version 1.1. Differences in the initial IVIM parameters [pure molecular diffusion (D), pseudo-diffusion coefficient (D*), and perfusion fraction (f)] between nodes with a partial response (PR) and a complete response (CR) were analyzed in 102 patients after the exclusion of 20.
The initial D*, D, and apparent diffusion coefficient (ADC) did not reveal a significant difference between nodes showing a PR or a CR. The mean initial f value was significantly higher in patients with a PR relative to patients with a CR (p = 0.003), and its sensitivity and specificity in predicting treatment response to chemoradiotherapy were 86.7% and 100%, respectively.
The present study indicated that the initial f value may be more accurate than the initial D*, D, and ADC in the early prediction of treatment response to chemoradiotherapy for metastatic lymph nodes in patients with NPC.
初步研究表明,体素内不相干运动(IVIM)磁共振成像(MRI)在头颈癌中具有潜在的临床应用价值。本研究旨在利用IVIM MRI对转移性淋巴结进行特征分析,并评估IVIM MRI在预测鼻咽癌(NPC)淋巴结转移早期治疗反应中的作用。
共有122例NPC转移性淋巴结患者接受了两次MRI检查,分别在治疗前和治疗后(化疗放疗结束后4周和≥2年)。使用实体瘤疗效评价标准1.1版评估治疗反应。在排除20例患者后,对102例患者中部分缓解(PR)和完全缓解(CR)的淋巴结之间初始IVIM参数[纯分子扩散(D)、伪扩散系数(D*)和灌注分数(f)]的差异进行了分析。
初始D*、D和表观扩散系数(ADC)在显示PR或CR的淋巴结之间未显示出显著差异。PR患者的平均初始f值显著高于CR患者(p = 0.003),其预测放化疗治疗反应的敏感性和特异性分别为86.7%和100%。
本研究表明,在早期预测NPC患者转移性淋巴结对放化疗的治疗反应方面,初始f值可能比初始D*、D和ADC更准确。